LATEST ALERTS
Cannabinoids
Developing countries could get economic boost from industrial hemp, says UN
25th January 2023 - News analysis |
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Senate passes bill that revises hemp product definition…
25th January 2023 - Alerts | North America, North Dakota, United States |
FDA publishes guidance for cannabis and clinical research…
25th January 2023 - Alerts | North America, United States |
CBD and THC to banned on hempseed labels…
25th January 2023 - Alerts | Asia, South Korea |
Japan CBD insights dashboard, Q3 2022
24th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in Japan, including information about product formats, pricing and brands
Netherlands CBD insights dashboard, Q3 2022
23rd January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the Netherlands, including information about product formats, pricing and brands
US CBD insights dashboard, Q3 2022
23rd January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the United States, including information about product formats, pricing and brands
France CBD insights dashboard, Q3 2022
19th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in France, including information about product formats, pricing and brands
Russia: CBD and cannabis regulation, January 2023
19th January 2023 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
UK CBD insights dashboard, Q3 2022
17th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the UK, including information about product formats, pricing and brands
Denmark: CBD and cannabis regulation, January 2023
17th January 2023 - Regulatory reports |
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
French court overturns government ban on hemp flowers, shops can sell again
16th January 2023 - News analysis |
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
Belgium: CBD and cannabis regulation, January 2023
16th January 2023 - Regulatory reports |
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Investigation over FDA inaction over CBD and hemp…
13th January 2023 - Alerts | North America, United States |
FDA expected to issue recommendation ‘soon’ on CBD regulation in the US
13th January 2023 - News analysis |
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
Germany CBD insights dashboard, Q3 2022
13th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in Germany, including information about product formats, pricing and brands
Much-needed research into SCRAs’ huge medical potential faces high barriers
12th January 2023 - Blogs |
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Google changes policy to allow advertising of certain CBD products…
9th January 2023 - Alerts | North America, United States |
FDA to make regulation recommendations for CBD…
9th January 2023 - Alerts | North America, United States |
Japan cannabinoid conference-goers look forward to future with legal reforms
9th January 2023 - News analysis |
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Monaco: CBD and cannabis regulation, January 2023
9th January 2023 - Regulatory reports |
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
Australia: CBD and cannabis regulation, January 2023
4th January 2023 - Regulatory reports |
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Is 2023 the year for the great leap forward on cannabis regulation?
3rd January 2023 - News analysis |
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
An overview of intoxicating hemp-derived cannabinoids in Europe
2nd January 2023 - Regulatory reports |
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
US FDA again issues warning letters on CBD in ingestibles, this time with a twist
30th December 2022 - News analysis |
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill
30th December 2022 - News analysis |
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The question of semi-synthetics – HHC comes under scrutiny by EU authorities
29th December 2022 - News analysis |
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
As legal cannabinoid markets spread, UN considers vexed question of regulation
20th December 2022 - News analysis |
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
Hong Kong to ban CBD in the new year, ending a once-burgeoning business
19th December 2022 - News analysis |
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
Minister responds to ACMD research on subject of research barriers…
19th December 2022 - Alerts | Europe, United Kingdom |
Government publishes Q&A on cooperatives and cannabis…
19th December 2022 - Alerts | Argentina, South America |
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Italy: CBD and cannabis regulation, December 2022
19th December 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Executives acquitted of fraud relating to cannabis production…
16th December 2022 - Alerts | Canada, North America |
Germany: CBD and cannabis snapshot
15th December 2022 - Market reports , Regulatory reports |
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Spain: CBD and cannabis snapshot
14th December 2022 - Market reports , Regulatory reports |
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Medical Marijuana and Cannabidiol Research Expansion Act signed into law…
5th December 2022 - Alerts | North America, United States |
Global cannabinoid vape compliance guide
2nd December 2022 - Regulatory reports |
The cannabinoid vape compliance guide goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive
Province lifts ban on some cannabis vapes…
2nd December 2022 - Alerts | Canada, North America |
Netherlands: CBD and cannabis snapshot
30th November 2022 - Market reports , Regulatory reports |
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
France: CBD and cannabis snapshot
29th November 2022 - Market reports , Regulatory reports |
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
